Literature DB >> 22609512

Novel tyrosine phosphorylation sites in rat skeletal muscle revealed by phosphopeptide enrichment and HPLC-ESI-MS/MS.

Xiangmin Zhang1, Kurt Højlund, Moulun Luo, Christian Meyer, Thangiah Geetha, Zhengping Yi.   

Abstract

Tyrosine phosphorylation plays a fundamental role in many cellular processes including differentiation, growth and insulin signaling. In insulin resistant muscle, aberrant tyrosine phosphorylation of several proteins has been detected. However, due to the low abundance of tyrosine phosphorylation (<1% of total protein phosphorylation), only a few tyrosine phosphorylation sites have been identified in mammalian skeletal muscle to date. Here, we used immunoprecipitation of phosphotyrosine peptides prior to HPLC-ESI-MS/MS analysis to improve the discovery of tyrosine phosphorylation in relatively small skeletal muscle biopsies from rats. This resulted in the identification of 87 distinctly localized tyrosine phosphorylation sites in 46 muscle proteins. Among them, 31 appear to be novel. The tyrosine phosphorylated proteins included major enzymes in the glycolytic pathway and glycogen metabolism, sarcomeric proteins, and proteins involved in Ca(2+) homeostasis and phosphocreatine resynthesis. Among proteins regulated by insulin, we found tyrosine phosphorylation sites in glycogen synthase, and two of its inhibitors, GSK-3α and DYRK1A. Moreover, tyrosine phosphorylation sites were identified in several MAP kinases and a protein tyrosine phosphatase, SHPTP2. These results provide the largest catalogue of mammalian skeletal muscle tyrosine phosphorylation sites to date and provide novel targets for the investigation of human skeletal muscle phosphoproteins in various disease states.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22609512      PMCID: PMC3398612          DOI: 10.1016/j.jprot.2012.05.009

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  56 in total

1.  Pyruvate kinase M2 is a phosphotyrosine-binding protein.

Authors:  Heather R Christofk; Matthew G Vander Heiden; Ning Wu; John M Asara; Lewis C Cantley
Journal:  Nature       Date:  2008-03-13       Impact factor: 49.962

2.  Global impact of oncogenic Src on a phosphotyrosine proteome.

Authors:  Weifeng Luo; Robbert J Slebos; Salisha Hill; Ming Li; Jan Brábek; Ramars Amanchy; Raghothama Chaerkady; Akhilesh Pandey; Amy-Joan L Ham; Steven K Hanks
Journal:  J Proteome Res       Date:  2008-06-19       Impact factor: 4.466

Review 3.  Signaling mechanisms in skeletal muscle: acute responses and chronic adaptations to exercise.

Authors:  Katja S C Röckl; Carol A Witczak; Laurie J Goodyear
Journal:  IUBMB Life       Date:  2008-03       Impact factor: 3.885

4.  Catalytic site of rabbit glycogen synthase isozymes. Identification of an active site lysine close to the amino terminus of the subunit.

Authors:  A M Mahrenholz; Y H Wang; P J Roach
Journal:  J Biol Chem       Date:  1988-08-05       Impact factor: 5.157

5.  Characterization of the human skeletal muscle proteome by one-dimensional gel electrophoresis and HPLC-ESI-MS/MS.

Authors:  Kurt Højlund; Zhengping Yi; Hyonson Hwang; Benjamin Bowen; Natalie Lefort; Charles R Flynn; Paul Langlais; Susan T Weintraub; Lawrence J Mandarino
Journal:  Mol Cell Proteomics       Date:  2007-10-01       Impact factor: 5.911

6.  Global relationship between the proteome and transcriptome of human skeletal muscle.

Authors:  Zhengping Yi; Benjamin P Bowen; Hyonson Hwang; Christopher P Jenkinson; Dawn K Coletta; Natalie Lefort; Mandeep Bajaj; Sangeeta Kashyap; Rachele Berria; Elena A De Filippis; Lawrence J Mandarino
Journal:  J Proteome Res       Date:  2008-07-10       Impact factor: 4.466

7.  Impaired insulin activation and dephosphorylation of glycogen synthase in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.

Authors:  Dorte Glintborg; Kurt Højlund; Nicoline R Andersen; Bo Falck Hansen; Henning Beck-Nielsen; Jørgen F P Wojtaszewski
Journal:  J Clin Endocrinol Metab       Date:  2008-06-10       Impact factor: 5.958

Review 8.  Impaired glycogen synthase activity and mitochondrial dysfunction in skeletal muscle: markers or mediators of insulin resistance in type 2 diabetes?

Authors:  Kurt Højlund; Henning Beck-Nielsen
Journal:  Curr Diabetes Rev       Date:  2006-11

9.  Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling.

Authors:  K Yamauchi; K L Milarski; A R Saltiel; J E Pessin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

10.  Phosphoproteome analysis of Drosophila melanogaster embryos.

Authors:  Bo Zhai; Judit Villén; Sean A Beausoleil; Julian Mintseris; Steven P Gygi
Journal:  J Proteome Res       Date:  2008-03-08       Impact factor: 4.466

View more
  1 in total

1.  Identification of Glioblastoma Phosphotyrosine-Containing Proteins with Two-Dimensional Western Blotting and Tandem Mass Spectrometry.

Authors:  Tianyao Guo; Xiaowei Wang; Maoyu Li; Haiyan Yang; Ling Li; Fang Peng; Xianquan Zhan
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.